Journal Club: Efficacy of Tocilizumab in Early Systemic Sclerosis–Related Interstitial Lung Disease

por Tiwari, Vivekanand, Rigby, William F.C.
Publicado 2021

Killing three birds with one BPI: Bactericidal, opsonic, and anti-inflammatory functions

por Theprungsirikul, Jomkuan, Skopelja-Gardner, Sladjana, Rigby, William F.C.
Publicado 2021

The thematic role of extracellular loop of VraG in activation of the membrane sensor GraS in a cystic fibrosis MRSA strain differs in nuance from the CA-MRSA strain JE2

por Cho, Junho, Rigby, William F. C., Cheung, Ambrose L.
Publicado 2022

A rheumatoid factor paradox: inhibition of rituximab effector function

por Jones, Jonathan D, Shyu, Irene, Newkirk, Marianna M, Rigby, William FC
Publicado 2013

Review of Routine Laboratory Monitoring for Patients with Rheumatoid Arthritis Receiving Biologic or Nonbiologic DMARDs

por Rigby, William F. C., Lampl, Kathy, Low, Jason M., Furst, Daniel E.
Publicado 2017

Bactericidal/Permeability-Increasing Protein Preeminently Mediates Clearance of Pseudomonas aeruginosa In Vivo via CD18-Dependent Phagocytosis

por Theprungsirikul, Jomkuan, Skopelja-Gardner, Sladjana, Burns, Ashley S., Wierzbicki, Rachel M., Rigby, William F. C.
Publicado 2021

The extracellular loop of the membrane permease VraG interacts with GraS to sense cationic antimicrobial peptides in Staphylococcus aureus

por Cho, Junho, Costa, Stephen K., Wierzbicki, Rachel M., Rigby, William F. C., Cheung, Ambrose L.
Publicado 2021

HLA-DRB1 risk alleles for RA are associated with differential clinical responsiveness to abatacept and adalimumab: data from a head-to-head, randomized, single-blind study in autoa...

por Rigby, William, Buckner, Jane H., Louis Bridges, S., Nys, Marleen, Gao, Sheng, Polinsky, Martin, Ray, Neelanjana, Bykerk, Vivian
Publicado 2021

Safety with Ocrelizumab in Rheumatoid Arthritis: Results from the Ocrelizumab Phase III Program

por Emery, Paul, Rigby, William, Tak, Paul P., Dörner, Thomas, Olech, Ewa, Martin, Carmen, Millar, Laurie, Travers, Helen, Fisheleva, Elena
Publicado 2014

Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial

por Burmester, Gerd R, Rigby, William F, van Vollenhoven, Ronald F, Kay, Jonathan, Rubbert-Roth, Andrea, Kelman, Ariella, Dimonaco, Sophie, Mitchell, Nina
Publicado 2016

Tocilizumab combination therapy or monotherapy or methotrexate monotherapy in methotrexate-naive patients with early rheumatoid arthritis: 2-year clinical and radiographic results...

por Burmester, Gerd R, Rigby, William F, van Vollenhoven, Ronald F, Kay, Jonathan, Rubbert-Roth, Andrea, Blanco, Ricardo, Kadva, Alysha, Dimonaco, Sophie
Publicado 2017

Safety of infusing rituximab at a more rapid rate in patients with rheumatoid arthritis: results from the RATE-RA study

por Pritchard, Charles H, Greenwald, Maria W, Kremer, Joel M, Gaylis, Norman B, Rigby, William, Zlotnick, Steve, Chung, Carol, Jaber, Birgit, Reiss, William
Publicado 2014

Regulation and localization of endogenous human tristetraprolin

por Fairhurst, Anna-Marie, Connolly, John E, Hintz, Katharine A, Goulding, Nicolas J, Rassias, Athos J, Yeager, Mark P, Rigby, William, Wallace, Paul K
Publicado 2003

Long-term effectiveness of live herpes zoster vaccine in patients with rheumatoid arthritis subsequently treated with tofacitinib

por Winthrop, Kevin L, Wouters, Ann, Choy, Ernest H, Chen, Connie, Biswas, Pinaki, Wang, Lisy, Soma, Koshika, Needle, Elie, Valdez, Hernan, Rigby, William FC
Publicado 2020

Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE

por Tak, Paul P, Rigby, William, Rubbert-Roth, Andrea, Peterfy, Charles, van Vollenhoven, Ronald F, Stohl, William, Healy, Emma, Hessey, Eva, Reynard, Mark, Shaw, Tim
Publicado 2011

Effect of tocilizumab on neutrophils in adult patients with rheumatoid arthritis: pooled analysis of data from phase 3 and 4 clinical trials

por Moots, Robert J., Sebba, Anthony, Rigby, William, Ostor, Andrew, Porter-Brown, Benjamin, Donaldson, Francis, Dimonaco, Sophie, Rubbert-Roth, Andrea, van Vollenhoven, Ronald, Genovese, Mark C.
Publicado 2017

Upadacitinib in Rheumatoid Arthritis: A Benefit–Risk Assessment Across a Phase III Program

por Conaghan, Philip G., Mysler, Eduardo, Tanaka, Yoshiya, Da Silva-Tillmann, Barbara, Shaw, Tim, Liu, John, Ferguson, Ryan, Enejosa, Jeffrey V., Cohen, Stanley, Nash, Peter, Rigby, William, Burmester, Gerd
Publicado 2021

The Safety and Immunogenicity of Live Zoster Vaccination in Patients With Rheumatoid Arthritis Before Starting Tofacitinib: A Randomized Phase II Trial

por Winthrop, Kevin L., Wouters, Ann G., Choy, Ernest H., Soma, Koshika, Hodge, Jennifer A., Nduaka, Chudy I., Biswas, Pinaki, Needle, Elie, Passador, Sherry, Mojcik, Christopher F., Rigby, William F.
Publicado 2017

Benefit–Risk Analysis of Upadacitinib Compared with Adalimumab in the Treatment of Patients with Moderate-to-Severe Rheumatoid Arthritis

por Conaghan, Philip, Cohen, Stanley, Burmester, Gerd, Mysler, Eduardo, Nash, Peter, Tanaka, Yoshiya, Rigby, William, Patel, Jayeshkumar, Shaw, Tim, Betts, Keith A., Patel, Pankaj, Liu, Jianzhong, Sun, Rochelle, Fleischmann, Roy
Publicado 2021

Regulation of Pseudomonas aeruginosa-Mediated Neutrophil Extracellular Traps

por Skopelja-Gardner, Sladjana, Theprungsirikul, Jomkuan, Lewis, Kimberley A., Hammond, John H., Carlson, Kyrsten M., Hazlett, Haley F., Nymon, Amanda, Nguyen, Dao, Berwin, Brent L., Hogan, Deborah A., Rigby, William F. C.
Publicado 2019